ArticleOncotarget2017

Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer.

Jair Machado Espindola-Netto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.